By
Bojan Pancevski and Gabriele Steinhauser
Published: July 26, 2021, 2:31 p.m.·
Tags:
Vaccines
BioNTech SE said it would invest some of the profits from the Covid-19 vaccine it markets with Pfizer Inc. into developing shots for malaria and tuberculosis in Africa, part of the German company’s plan to establish a large production hub for innovative medicines on the continent.
Read More →